Octreopharm Sciences

Theranostic compounds for neuroendocrine tumours.

placeBerlin, Berlin, Germany calendar_todayFounded 2009 groups11 employees language octreopharmsciences.com

Registered entities

Investor mix

3 investors on record; lead investors include Eckert Life Science Accelerator, Kfw, IBB Ventures.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon